Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemia.

Schliffke S, Buhs S, Bolz S, Gerull H, von Wenserski L, Riecken K, Fehse B, Nollau P, Binder M.

Blood. 2018 Apr 12;131(15):1755-1758. doi: 10.1182/blood-2017-06-788166. Epub 2018 Feb 23. No abstract available.

PMID:
29475960
2.

SH2 Domain Histochemistry.

Buhs S, Nollau P.

Methods Mol Biol. 2017;1555:535-545. doi: 10.1007/978-1-4939-6762-9_31.

PMID:
28092054
3.

Identification of Tyrosine Phosphorylated Proteins by SH2 Domain Affinity Purification and Mass Spectrometry.

Buhs S, Gerull H, Nollau P.

Methods Mol Biol. 2017;1555:407-418. doi: 10.1007/978-1-4939-6762-9_23.

PMID:
28092046
4.

Reverse phase protein arrays enable glioblastoma molecular subtyping.

Hutter G, Sailer M, Azad TD, von Bueren AO, Nollau P, Frank S, Tostado C, Sarvepalli D, Ghosh A, Ritz MF, Boulay JL, Mariani L.

J Neurooncol. 2017 Feb;131(3):437-448. doi: 10.1007/s11060-016-2316-5. Epub 2016 Nov 17.

PMID:
27858266
5.

Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking.

Braig F, Brandt A, Goebeler M, Tony HP, Kurze AK, Nollau P, Bumm T, Böttcher S, Bargou RC, Binder M.

Blood. 2017 Jan 5;129(1):100-104. doi: 10.1182/blood-2016-05-718395. Epub 2016 Oct 26.

6.

Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma.

Fichtner M, Spies E, Seismann H, Riecken K, Engels N, Gösch B, Dierlamm J, Gerull H, Nollau P, Klapper W, Dreyling M, Binder M, Trepel M.

Haematologica. 2016 Sep;101(9):e378-81. doi: 10.3324/haematol.2016.141929. No abstract available.

7.

The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.

Baldauf C, Jeschke A, Kanbach V, Catala-Lehnen P, Baumhoer D, Gerull H, Buhs S, Amling M, Nollau P, Harroch S, Schinke T.

PLoS One. 2015 Sep 11;10(9):e0137745. doi: 10.1371/journal.pone.0137745. eCollection 2015.

8.

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.

Frietsch JJ, Kastner C, Grunewald TG, Schweigel H, Nollau P, Ziermann J, Clement JH, La Rosée P, Hochhaus A, Butt E.

Oncotarget. 2014 Jul 30;5(14):5257-71.

9.

Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.

Beck F, Geiger J, Gambaryan S, Veit J, Vaudel M, Nollau P, Kohlbacher O, Martens L, Walter U, Sickmann A, Zahedi RP.

Blood. 2014 Jan 30;123(5):e1-e10. doi: 10.1182/blood-2013-07-512384. Epub 2013 Dec 9.

10.

Functional interaction of SCAI with the SWI/SNF complex for transcription and tumor cell invasion.

Kreßner C, Nollau P, Grosse R, Brandt DT.

PLoS One. 2013 Aug 2;8(8):e69947. doi: 10.1371/journal.pone.0069947. Print 2013.

11.

Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.

Schweigel H, Geiger J, Beck F, Buhs S, Gerull H, Walter U, Sickmann A, Nollau P.

Proteomics. 2013 Mar;13(6):1016-27. doi: 10.1002/pmic.201200353. Epub 2013 Feb 18.

PMID:
23322602
12.

Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues.

Nollau P, Wolters-Eisfeld G, Mortezai N, Kurze AK, Klampe B, Debus A, Bockhorn M, Niendorf A, Wagener C.

J Histochem Cytochem. 2013 Mar;61(3):199-205. doi: 10.1369/0022155412474823. Epub 2012 Dec 28.

13.

Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling.

Machida K, Khenkhar M, Nollau P.

Genes Cancer. 2012 May;3(5-6):353-61. doi: 10.1177/1947601912459048.

14.

Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression.

Otto B, Gruner K, Heinlein C, Wegwitz F, Nollau P, Ylstra B, Pantel K, Schumacher U, Baumbusch LO, Martin-Subero JI, Siebert R, Wagener C, Streichert T, Deppert W, Tolstonog GV.

Int J Cancer. 2013 Mar 15;132(6):1300-10. doi: 10.1002/ijc.27783. Epub 2012 Sep 26.

15.

Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes.

Heine M, Nollau P, Masslo C, Nielsen P, Freund B, Bruns OT, Reimer R, Hohenberg H, Peldschus K, Ittrich H, Schumacher U.

PLoS One. 2011;6(12):e28030. doi: 10.1371/journal.pone.0028030. Epub 2011 Dec 5.

16.

Generating high-quality protein binders: a large screening effort pays off.

Nollau P.

Nat Methods. 2011 Jun 29;8(7):545-6. doi: 10.1038/nmeth.1632. No abstract available.

PMID:
21716281
17.

Quantitative MR imaging of targeted SPIO particles on the cell surface and comparison to flow cytometry.

Peldschus K, Schultze A, Nollau P, Kaul M, Schumacher U, Wagener C, Adam G, Ittrich H.

Magn Reson Imaging. 2010 May;28(4):599-606. doi: 10.1016/j.mri.2009.12.017. Epub 2010 Feb 1.

PMID:
20117898
18.

DC-SIGN and SRCL bind glycans of carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1): recombinant human glycan-binding receptors as analytical tools.

Samsen A, Bogoevska V, Klampe B, Bamberger AM, Lucka L, Horst AK, Nollau P, Wagener C.

Eur J Cell Biol. 2010 Jan;89(1):87-94. doi: 10.1016/j.ejcb.2009.11.018.

PMID:
20034698
19.

Approaching clinical proteomics: current state and future fields of application in cellular proteomics.

Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R, Kubicek M, Lottspeich F, Maser E, Mewes HW, Meyer HE, Müllner S, Mutter W, Neumaier M, Nollau P, Nothwang HG, Ponten F, Radbruch A, Reinert K, Rothe G, Stockinger H, Tárnok A, Taussig MJ, Thiel A, Thiery J, Ueffing M, Valet G, Vandekerckhove J, Wagener C, Wagner O, Schmitz G.

Cytometry A. 2009 Oct;75(10):816-32. doi: 10.1002/cyto.a.20779. Review.

20.

Approaching clinical proteomics: current state and future fields of application in fluid proteomics.

Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R, Kubicek M, Lottspeich F, Maser E, Mewes HW, Meyer HE, Müllner S, Mutter W, Neumaier M, Nollau P, Nothwang HG, Ponten F, Radbruch A, Reinert K, Rothe G, Stockinger H, Tarnok A, Taussig MJ, Thiel A, Thiery J, Ueffing M, Valet G, Vandekerckhove J, Verhuven W, Wagener C, Wagner O, Schmitz G.

Clin Chem Lab Med. 2009;47(6):724-44. doi: 10.1515/CCLM.2009.167. Review.

PMID:
19527139

Supplemental Content

Loading ...
Support Center